Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerBilling CodesInjection and Intravenous Infusion Chemotherapy and Other Highly Complex Drug or Highly Complex Biologic Agent AdministrationCPT cpt-96415-additional-hour-chemotherapy-intravenous-infusion
    Ask Trek AI about this page

    CPT 96415: Continued Intravenous Chemotherapy Infusion, Per Additional Hour

    Medicare pays $29 and commercial payers pay $83 on average nationally for this procedure.

    CPT code 96415 is an add-on chemotherapy infusion code describing continued intravenous administration of a chemotherapy drug using an infusion technique for each additional hour beyond the initial hour during the same patient session; service type: chemotherapy infusion administration (intravenous); typical site of service: outpatient infusion center or hospital outpatient department.

    For related coverage guidance, see recent payer policy updates: Bendamustine Products Coverage Criteria, T-Cell Lymphoma Agents: Beleodaq, Istodax, Lymphir, Poteligeo, and Romidepsin, Brentuximab Vedotin (Adcetris®) Coverage Criteria.

    Customize your policy alerts

    Sign up for cpt 96415 policy alerts

    Get alerted when payer policies referencing 96415 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    National Reimbursement Benchmarks

    Nationally, Medicare averages $29.4 for CPT 96415 while BUCA’s mean commercial rate is substantially higher at $82.7, reflecting a roughly $53.3 gap between public and this commercial benchmark. Blue Cross Blue Shield’s mean of $101.6 and Aetna’s mean of $77.1 also sit above Medicare, while Cigna and UnitedHealth Group have means closer to BUCA and below BCBS, illustrating a clear separation between Medicare and major commercial payers.

    Dispersion measured as the interquartile spread (P75 minus P25) varies meaningfully: Aetna’s IQR is $50.5, Blue Cross Blue Shield’s is $40.1, BUCA’s is $37.8, Cigna’s is $33.8, and UnitedHealth Group’s is $25.0. UnitedHealth Group therefore shows the tightest middle distribution and Aetna the widest, with BUCA and BCBS indicating moderate commercial variability around their means.

    Table of contents

    Progress1 / 8

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • Facility ComparisonBeds, revenue & payer mix
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools
    National Payer Mean Reimbursement Rates

    State Reimbursement Rates

    State: Alaska1 / 51

    Rate by payer

    Clinical & Coding Specifications

    Clinical Context

    A 62-year-old patient with metastatic colon cancer (C18.9) presents to an outpatient oncology infusion suite for a planned chemotherapy session. The oncology nurse initiates an IV infusion of the primary cytotoxic agent and documents the first hour of infusion under the initial intravenous infusion code. The patient requires continued infusion of the same chemotherapy drug beyond the first hour during the same visit due to the prescribed dosing schedule. The oncologist documents ongoing infusion time and the provider reports the add-on code 96415 for each additional full hour of continuous intravenous infusion of the same drug beyond the initial hour. The typical workflow includes patient check-in, review of diagnoses and chemotherapy orders, intravenous access verification, medication preparation by pharmacy, administration and continuous monitoring by nursing staff for adverse reactions, documentation of infusion start and stop times, and final provider review and sign-off before discharge.

    Related CPT Codes

    CPT CodeDescriptionRelationship to This Procedure
    96413Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drugThe primary code used to report the first hour of infusion during the same session; is reported only for additional hours beyond this initial hour.

    Related Modifiers

    5 rows

    ModifierDescriptionWhen to Use
    76Modifier -76, Repeat Procedure or Service by Same Physician or Other Qualified Health Care Professional, is appended when the same provider performs an identical, medically necessary procedure or…- Use modifier -76 when the same physician or other qualified health care professional performs an identical procedure or service a second (or subsequent) time on the same date of service and the…
    52Modifier ‑52 (Reduced Services) indicates that a service or procedure was partially reduced or omitted at the provider’s discretion, allowing reporting of the basic procedure number with a qualifier…- Use modifier -52 when a physician or qualified health professional electively reduces or omits part of a procedure or service (for example, performing fewer required views or omitting a portion of…
    59Modifier 59 indicates a distinct procedural service when two procedures that are not normally billed together are clinically and procedurally separate. The CPT definition (as reiterated by CMS)…- Use modifier -59 to report a distinct procedural service when documentation supports that the procedure reported is not normally billed together with another service on the same day because of a…
    78CPT modifier -78 indicates an unplanned, related return to the operating or procedure room by the same provider during the global postoperative period. It is appended when treatment for a…- Use modifier -78 when an unplanned, related complication during the original procedure’s global postoperative period requires the patient to return to a formal operating or procedure room and the…
    96Modifier 96 is appended to CPT codes to indicate that a service or procedure was provided for habilitative purposes — i.e., to help a patient learn, maintain, or improve skills and functioning for…- Use modifier -96 when a procedure or service that could be either habilitative or rehabilitative is provided specifically for habilitative purposes — i.e., to help a patient learn, maintain, or…

    Related Provider Taxonomies

    8 rows

    Taxonomy Code
    207RH0003X
    207RX0202X
    2085R0202X
    207RB0002X
    2251S0007X
    2082S0099X
    2080P0201X
    224Z00000X

    Related Payer Policy Updates

    Specialty: Hematology/Oncology1 / 3

    10 rows

    PolicyPayerEffective Date
    Bendamustine Products Coverage Criteriablue cross blue shield - tennessee2027-01-30
    T-Cell Lymphoma Agents: Beleodaq, Istodax, Lymphir, Poteligeo, and RomidepsinMass General Brigham Health Plan2027-01-04
    Brentuximab Vedotin (Adcetris®) Coverage Criteriablue cross blue shield - tennessee2026-12-31
    Pemetrexed Coverageblue cross blue shield - tennessee2026-12-31
    Tumor Treatment Fields - Medical PolicyHealth-New-England2026-12-01
    Extracorporeal PhotopheresisCigna2026-11-15
    Hematology - AphexdaCigna2026-11-15
    VonvendiCigna2026-11-15
    Extracorporeal PhotopheresisCigna2026-11-15
    Yartemlea (narsoplimab-wuug) Coverage for TA-TMANeighborhood Health Plan of Rhode Island2026-11-01

    Related Codes

    CPT-96401-SUBCUTANEOUS-INTRAMUSCULAR-CHEMOTHERAPY-ADMINISTRATION

    CPT 96401: Subcutaneous or Intramuscular Nonhormonal Chemotherapy

    CPT-96402-SUBCUTANEOUS-INTRAMUSCULAR-HORMONAL-ANTINEOPLASTIC-ADMINISTRATION

    CPT 96402: Subcutaneous/Intramuscular Hormonal Anti‑Neoplastic Administration

    CPT-96405-INTRALESIONAL-CHEMOTHERAPY-ONE-TO-SEVEN-LESIONS

    CPT 96405: Intralesional Chemotherapy, 1–7 Lesions

    CPT-96406-INTRALESIONAL-CHEMOTHERAPY-MORE-THAN-7-LESIONS

    CPT 96406: Intralesional Chemotherapy for >7 Lesions

    CPT-96409-INTRAVENOUS-PUSH-CHEMOTHERAPY-INITIAL-DRUG

    CPT 96409: Intravenous Push Chemotherapy, Single/Initial Drug

    CPT-96411-ADD-ON-INTRAVENOUS-PUSH-CHEMOTHERAPY-DRUG

    CPT 96411: Add-On IV Push for Additional Chemotherapy Drug

    CPT-96413-INTRAVENOUS-CHEMOTHERAPY-INFUSION-INITIAL-HOUR

    CPT 96413: Intravenous Chemotherapy Infusion, Initial Hour

    CPT-96416-CHEMOTHERAPY-INITIATION-PORTABLE-IMPLANTABLE-PUMP

    CPT 96416: Initiation of Intravenous Chemotherapy via Pump

    CPT-96417-ADD-ON-IV-CHEMOTHERAPY-INFUSION-DIFFERENT-AGENT

    CPT 96417: Continued Intravenous Chemotherapy Administration

    Frequently Asked Questions

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

    96415

    96417 | Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (list separately in addition to code for primary procedure) | Used when a different chemotherapy drug is infused sequentially in the same visit; this is reported in addition to the primary initial code and is distinct from 96415 which is for additional time of the same drug.